Favrille Gets $45M In Private Placement

San Diego-based Favrille has received a private placement worth $45M. The publicly held firm said that it has received the $45M from MPM BioEquities, with participation by Federated Kaufmann Fund, T. Rowe Price Associates, Tang Capital Management, ProMed Management, Forward Ventures, Sanderling Ventures, Alloy Ventures and William Blair Capital Partners. The firm said that the funding would be used to continue clinical development of its treatment for non-Hodkin's lymphoma, and to aggressively prepare for commercial launch.